Nathan Eddy
Forty million people a day are using AI to get answers about their symptoms and healthcare coverage.
Non-labor expense increases of 6% to 10% over the past year were driven in part by tariffs, says Kaufman Hall report.
At-risk clinicians who cite misalignment with leadership as their primary reason for leaving are also the least satisfied with their EHRs.
Starting January 1, 340B hospitals will pay large sums upfront to buy drugs at the full wholesale acquisition price, lawsuit says.
There are increased monthly premiums, out-of-pocket costs and the elimination of some Medicare Advantage plans entirely.
Hospitals increasingly see ASCs not only as a budget item but as a central element of strategy, report says.
A stronger in-house data structure may be a factor into Pharma's prioritization of AI.
Tariffs and drug pricing reforms are a top priority, overtaking traditional concerns such as workforce challenges and cybersecurity.
Senior leaders feel pressure to evolve AI but cite a lack of internal resources to develop in-house AI tools.
Execs are eager to use genAI to optimize workflow and improve clinical sustainability, but a readiness gap persists.